BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35261045)

  • 21. A new proposed tumor-node-metastasis-age staging system for stage IV medullary thyroid carcinoma based on the SEER database.
    Li M; Huang Y; Wang M; Zeng W; Chen S; Zhou W; Wei W; Zhang C; Hu D; Huang J; Liu Z; Guo L
    Am J Transl Res; 2021; 13(6):6098-6107. PubMed ID: 34306348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
    Torresan F; Cavedon E; Mian C; Iacobone M
    World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-1/PD-L1 expressions in medullary thyroid carcinoma: Clinicopathologic and prognostic analysis of Chinese population.
    Bi Y; Ren X; Bai X; Meng Y; Luo Y; Cao J; Zhang Y; Liang Z
    Eur J Surg Oncol; 2019 Mar; 45(3):353-358. PubMed ID: 30528043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.
    Tang J; Jiang S; Gao L; Xi X; Zhao R; Lai X; Zhang B; Jiang Y
    Ann Surg Oncol; 2021 Aug; 28(8):4360-4370. PubMed ID: 33469797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factor analysis of distant metastases in patients with primary medullary thyroid cancer: a population-based study.
    Su H; Men Q; Hao J; Zhang F
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1525-1530. PubMed ID: 38112760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk and survival of patients with medullary thyroid cancer: National perspective.
    Al-Qurayshi Z; Khadra H; Chang K; Pagedar N; Randolph GW; Kandil E
    Oral Oncol; 2018 Aug; 83():59-63. PubMed ID: 30098780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer.
    Valenciaga A; Grubbs EG; Porter K; Wakely PE; Williams MD; Cote GJ; Vasko VV; Saji M; Ringel MD
    Thyroid; 2017 Dec; 27(12):1523-1533. PubMed ID: 29105562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival.
    Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H
    J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
    Yeh T; Yeung M; Sherman EJ; Tuttle RM; Sabra MM
    Thyroid; 2020 Aug; 30(8):1112-1119. PubMed ID: 32131709
    [No Abstract]   [Full Text] [Related]  

  • 30. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness.
    Voss RK; Feng L; Lee JE; Perrier ND; Graham PH; Hyde SM; Nieves-Munoz F; Cabanillas ME; Waguespack SG; Cote GJ; Gagel RF; Grubbs EG
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2807-2813. PubMed ID: 28609830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old.
    Yang B; Niu G; Li X; Ma F; Ma Y; Hu S
    Front Endocrinol (Lausanne); 2022; 13():1015319. PubMed ID: 36339396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.
    Torresan F; Mian C; Cavedon E; Iacobone M
    Langenbecks Arch Surg; 2019 Jun; 404(4):411-419. PubMed ID: 30903267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial.
    Chen J; Ji Q; Bai C; Zheng X; Zhang Y; Shi F; Li X; Tang P; Xu Z; Huang R; Huang T; Pan Y; Fan S; Zhou J; Su W
    Thyroid; 2020 Sep; 30(9):1245-1253. PubMed ID: 32075524
    [No Abstract]   [Full Text] [Related]  

  • 34. Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma.
    Shi X; Yu PC; Lei BW; Li CW; Zhang Y; Tan LC; Shi RL; Wang J; Ma B; Xu WB; Wang X; Hu JQ; Huang NS; Wei WJ; Wang Y; Chen TZ; Wang YL; Ji QH
    Thyroid; 2019 Sep; 29(9):1269-1278. PubMed ID: 31328653
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
    Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
    Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma.
    Zhou TH; Zhao LQ; Zhang Y; Wu F; Lu KN; Mao LL; Jiang KC; Luo DC
    Front Endocrinol (Lausanne); 2021; 12():741289. PubMed ID: 34867784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
    Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
    Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
    [No Abstract]   [Full Text] [Related]  

  • 38. A Novel N Staging System for Predicting Survival in Patients with Medullary Thyroid Cancer.
    Chen L; Qian K; Guo K; Zheng X; Sun W; Sun T; Wang Y; Li D; Wu Y; Ji Q; Wang Z
    Ann Surg Oncol; 2019 Dec; 26(13):4430-4438. PubMed ID: 31552613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
    Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
    JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014: A Nationwide Study.
    Mathiesen JS; Kroustrup JP; Vestergaard P; Stochholm K; Poulsen PL; Rasmussen ÅK; Feldt-Rasmussen U; Schytte S; Londero SC; Pedersen HB; Hahn CH; Bentzen J; Möller S; Gaustadnes M; Rossing M; Nielsen FC; Brixen K; Frederiksen AL; Godballe C
    Thyroid; 2019 Mar; 29(3):368-377. PubMed ID: 30618340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.